PT Brigit Biofarmaka Technologi Tbk (IDX:OBAT)

IDX:OBAT Balance Sheet

Financials in millions IDR. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	26,934	29,320	6,371	3,988	989.7	1,964
Short-Term Investments	21,320	13,320	820	-	-	-
Cash & Short-Term Investments	48,254	42,640	7,191	3,988	989.7	1,964
Cash Growth	18.80%	492.92%	80.34%	302.93%	-49.60%	-
Accounts Receivable	10,510	5,630	3,878	2,616	611.4	605.18
Other Receivables	918.35	43.88	34.21	-	-	-
Receivables	11,429	5,673	3,912	2,616	611.4	605.18
Inventory	28,344	22,666	20,080	8,006	5,061	3,332
Prepaid Expenses	774.24	1,563	1,321	-	-	-
Other Current Assets	2,765	547.14	2,592	27	19.17	19.17
Total Current Assets	91,567	73,089	35,096	14,637	6,681	5,921
Property, Plant & Equipment	50,666	41,049	23,233	18,743	13,155	7,124
Long-Term Investments	124.09	124.09	176.02	354.81	375.08	-
Goodwill	802.57	802.57	-	-	-	-
Long-Term Deferred Tax Assets	87.57	82.09	11.52	6.73	2.14	1.54
Other Long-Term Assets	20,999	15,857	7,369	2,557	5,453	11,729
Total Assets	164,245	131,004	65,886	36,298	25,666	24,775

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	2,696	900.06	376.95	881.16	743.39	314.6
Accrued Expenses	2,957	1,824	831.64	1,078	124.64	-
Current Portion of Long-Term Debt	1,805	1,396	527.08	27.36	250.53	27.36
Current Portion of Leases	231.48	55.98	59.12	96.38	63.01	47.18
Current Income Taxes Payable	4,802	6,018	7,844	10,308	7,411	4,186
Current Unearned Revenue	1,380	804.9	1,794	2,452	1,383	1,488
Total Current Liabilities	13,871	10,998	11,433	14,843	9,975	6,063
Long-Term Debt	7,620	5,662	8,523	1,427	29.64	57
Long-Term Leases	151.83	327.99	398.98	238.03	36.97	44.24
Pension & Post-Retirement Benefits	47.98	47.98	20.76	16.99	5.11	2.5
Other Long-Term Liabilities	424.73	3,953	1,820	429.32	244.54	316.56
Total Liabilities	22,116	20,989	22,196	16,955	10,292	6,483

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	34,019	30,000	21,500	2,000	2,000	500
Additional Paid-In Capital	72,162	48,049	505.71	1,361	1,522	-
Retained Earnings	31,068	28,884	20,252	16,651	12,379	16,010
Comprehensive Income & Other	-7.13	-7.13	1.01	-1,397	-1,058	1,671
Total Common Equity	137,242	106,926	42,259	18,616	14,843	18,182
Minority Interest	4,888	3,089	1,431	727.9	531.26	109.83
Shareholders' Equity	142,129	110,015	43,690	19,344	15,374	18,292
Total Liabilities & Equity	164,245	131,004	65,886	36,298	25,666	24,775

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	9,809	7,441	9,509	1,789	380.15	175.78
Net Cash (Debt)	38,446	35,199	-2,317	2,199	609.54	1,788
Net Cash Growth	25.72%	-	-	260.71%	-65.91%	-
Net Cash Per Share	60.05	58.66	-3.86	5.11	1.32	3.86
Filing Date Shares Outstanding	680.38	600	600	40	463	463
Total Common Shares Outstanding	680.38	600	600	40	463	463
Working Capital	77,695	62,091	23,663	-206.08	-3,294	-142.5
Book Value Per Share	201.71	178.21	70.43	465.39	32.06	39.27
Tangible Book Value	136,439	106,124	42,259	18,616	14,843	18,182
Tangible Book Value Per Share	200.53	176.87	70.43	465.39	32.06	39.27
Land	7,110	7,110	2,310	2,310	-	-
Buildings	30,886	22,647	13,910	10,665	9,523	4,961
Machinery	23,644	20,127	12,683	10,117	6,209	3,492

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 29, 2026

Data Sources Report a data error